About 1 in 8 adults in the United States has used a GLP-1 drug like Ozempic or Mounjaro at some point in their life, and half ...
A poll from the health policy nonprofit KFF found that 1 in 8 adults say they’ve taken a GLP-1 agonist, the obesity and ...
One in eight adults (12 percent) say they have ever taken a glucagon-like peptide-1 receptor agonist (GLP-1 RA) and 6 percent say they are currently using one, ...
Structure Therapeutics reported Monday that its oral GLP-1 drug led to weight loss in two studies, leading shares to surge in ...
GLP-1s have exploded in popularity, to the where, a ccording to the Kaiser Family Foundation, 12% of adults has taken Ozempic ...
Medications for type 2 diabetes and obesity known as GLP-1 receptor agonists may lower the risk of acute pancreatitis recurrence in people with obesity and those with type 2 diabetes, according to a ...
"Does your insurance cover anti-obesity drugs?" Laura Davisson, MD, once again asked the patient before her. She said these cost-of-care conversations are now a daily occurrence. While glucagon-like ...
Ozempic and Wegovy might help lower the risk of pancreatitis in patients with obesity and type 2 diabetes, a new study ...
More than three out of four young adults prescribed GLP-1 drugs last year were women, new research shows–raising questions ...
Nestlé has created a new frozen food line, aimed at people taking GLP-1 medications. Experts say maintaining a healthy diet ...
More than 40% of adults in the United States live with obesity, and the percentage of people living with obesity continues to increase dramatically. While experts have learned a great deal about the ...
Wegovy, Ozempic and now retatrutide – the ‘miracle’ drugs are booming, but are they safe and how do they stack up?